HAL (France)open access
Glycoprotein IIb / IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with newer P2Y12 inhibitors
Acute coronary syndrome, Ticagrelor, 0, Glycoprotein IIb/IIIa inhibitors, P2Y12 inhibitors, Prasugrel, ST segment elevation myocardial infarction
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 670167
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.